What are the future movements of Shire Korea?

A Korean branch of the British pharmaceutical company, Shire, which was in the middle of the global M&A issue last year, also known as Shire Korea, cleared the industry.

In order to establish the domestic branch, Shire appointed CEO Hui-seok Moon last year and prepared to expand to the Korean market.

Prior to the launch of the Fabry’s disease, Replagal, Shire Korea, which has been vague so fa...